This is a Validated Antibody Database (VAD) review about human KRT6A, based on 97 published articles (read how Labome selects the articles), using KRT6A antibody in all methods. It is aimed to help Labome visitors find the most suited KRT6A antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
KRT6A synonym: CK-6C; CK-6E; CK6A; CK6C; CK6D; K6A; K6C; K6D; KRT6C; KRT6D; PC3

Invitrogen
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 6b
Invitrogen KRT6A antibody (eBioscience, 53-9003-82) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6b). Commun Biol (2022) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 2, 4a, 4b
Invitrogen KRT6A antibody (InVitrogen, MA5-13156) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 2, 4a, 4b). Mol Oncol (2022) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 2b
Invitrogen KRT6A antibody (Lab Vision, MS-343-P) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2b). Sci Adv (2021) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; dogs; fig 2g
Invitrogen KRT6A antibody (Zymed, D5/16B4) was used in immunohistochemistry on dogs samples (fig 2g). Animals (Basel) (2021) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human; loading ...
Invitrogen KRT6A antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples . Nat Commun (2021) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
Invitrogen KRT6A antibody (eBioscience, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 4a). Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; rhesus macaque; 0.2 ug/ml; loading ...; fig 4g
Invitrogen KRT6A antibody (Thermo Fisher, 41-9003-82) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 0.2 ug/ml (fig 4g). Science (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1a
Invitrogen KRT6A antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1a). Nat Cell Biol (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; fig 4, 5
Invitrogen KRT6A antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples (fig 4, 5). Breast Cancer Res (2019) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; human; loading ...; fig s1b
In order to study the suppressive effect of DNAJB6 and Hsp70 on alpha-synuclein aggregation, Invitrogen KRT6A antibody (Thermo Fischer, MA5-13203) was used in immunocytochemistry on human samples (fig s1b). Sci Rep (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; tbl 2
In order to describe the differences between Xp11 translocation renal cell carcinoma and the corresponding mesenchymal neoplasm, Invitrogen KRT6A antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (AE3)
  • flow cytometry; human; loading ...
In order to examine epithelial cell populations from touch samples, Invitrogen KRT6A antibody (eBioscience, 14-900-80) was used in flow cytometry on human samples . F1000Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5b
In order to determine the effects of repeated diacetyl vapor exposures on 3D organotypic cultures of human primary tracheobronchial epithelial cells, Invitrogen KRT6A antibody (Thermo, PA5-28235) was used in western blot on human samples (fig 5b). J Proteome Res (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; loading ...; fig 3d
In order to discuss a case of mixed adenoneuroendocrine carcinoma of stomach with tubular adenoma and well-differentiated neuroendocrine tumor in the primary tumor in the stomach, Invitrogen KRT6A antibody (Thermo Scientific, AE1-AE3) was used in immunohistochemistry on human samples (fig 3d). Case Rep Pathol (2016) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:75; tbl 2
In order to use MAML2 staining to distinguish cases of hyalinizing clear cell carcinoma from mucoepidermoid carcinoma, Invitrogen KRT6A antibody (Thermo Scientific, D5/16 B4) was used in immunohistochemistry - paraffin section on human samples at 1:75 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; mouse; loading ...; fig 3c
  • western blot; mouse; loading ...; fig 3d
In order to identify keratin-associated protein 5-5 as a driver of endothelial monolayer invasion, Invitrogen KRT6A antibody (Thermo Scientific, MA5-13203) was used in immunocytochemistry on mouse samples (fig 3c) and in western blot on mouse samples (fig 3d). Oncogene (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5b
In order to investigate inflammatory responses present at the breast cancer biopsy wound site, Invitrogen KRT6A antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 5b). Breast Cancer Res Treat (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:50; fig 1
In order to analyze the induction of apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue by cisplatin and doxorubicin, Invitrogen KRT6A antibody (ThermoFisher Scientific, MA5-13156) was used in immunocytochemistry on human samples at 1:50 (fig 1). Future Oncol (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; fig s3
In order to test if the operating room environment contains human skin bacteria that could be seeding C-section born infants, Invitrogen KRT6A antibody (Molecular Probes, 985542A) was used in immunohistochemistry - paraffin section on human samples (fig s3). Microbiome (2015) ncbi
mouse monoclonal (PAN-CK)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to describe functionally enriched ES cell transgenics, Invitrogen KRT6A antibody (Thermo Scientific, MA5-13203) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Sci Rep (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
In order to determine the desmoplastic interface in xenograft tumor in mice comprised of stromal and endothelial cells, Invitrogen KRT6A antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Pathol Res Pract (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; mouse; 1:100; loading ...; tbl 2
In order to investigate if conditioned medium from proliferating fibroblasts induce a subset of hematopoietic cells to become adherent fibroblast-like cells, Invitrogen KRT6A antibody (eBioscience, 41-9003) was used in immunocytochemistry on mouse samples at 1:100 (tbl 2). J Cell Physiol (2016) ncbi
mouse monoclonal (D5/I6 B4)
  • immunohistochemistry; human; ready to use
In order to evaluate the expression of CD24, CD44, CD133 and ALDH1 in invasive ductal carcinoma of the breast, Invitrogen KRT6A antibody (Thermo Scientific, MS-1814-R7) was used in immunohistochemistry on human samples at ready to use. Pathol Res Pract (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 2
In order to study a northern New England hospital and increased utilization, verification, and clinical implications of immunocytochemistry, Invitrogen KRT6A antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry on human samples (tbl 2). Diagn Cytopathol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; carp
In order to establish and characterize a new cell line generated from the caudal fin tissue of ornamental common carp, Invitrogen KRT6A antibody (Life Technologies, MA5-13156) was used in immunocytochemistry on carp samples . In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human
  • immunocytochemistry; human; 1 ul
Invitrogen KRT6A antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples and in immunocytochemistry on human samples at 1 ul. Nanomedicine (2015) ncbi
mouse monoclonal (C11)
  • western blot; human; 1:1000
In order to develop an immunofluorescence method to assess MCT1 and MCT4 in circulating tumor cells and as them as biomarkers of AZD3965 in cancer patients, Invitrogen KRT6A antibody (Thermo Scientific, 4545) was used in western blot on human samples at 1:1000. BMC Cancer (2015) ncbi
mouse monoclonal (PAN-CK)
  • western blot; human
In order to study the impact of TNF-alpha and IL-1beta on the inflammatory phenotype of cancer-associated fibroblasts and mesenchymal stem/stromal cells, Invitrogen KRT6A antibody (Thermo Fisher Scientific, MA5-13203) was used in western blot on human samples . Stem Cell Res Ther (2015) ncbi
mouse monoclonal (AE1/AE3)
In order to generate and characterize a thymic cell line derived from Channa striatus, Invitrogen KRT6A antibody (Invitrogen, AE1/AE3) was used . In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 10-20 ug/ml
In order to identify biomarkers for nasopharyngeal carcinoma, Invitrogen KRT6A antibody (Lab.Vision, Ab-1) was used in immunohistochemistry - paraffin section on human samples at 10-20 ug/ml. Asian Pac J Cancer Prev (2015) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; cat; 1:100
  • immunohistochemistry - paraffin section; dogs; 1:100
Invitrogen KRT6A antibody (Zymed, D5/16B4) was used in immunohistochemistry - paraffin section on cat samples at 1:100 and in immunohistochemistry - paraffin section on dogs samples at 1:100. J Comp Pathol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen KRT6A antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (AE3)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen KRT6A antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human
In order to characterize two cases of primary thymic adenocarcinoma with enteric differentiation, Invitrogen KRT6A antibody (Thermo Scientific, clone D5/16 B4) was used in immunohistochemistry - paraffin section on human samples . Am J Surg Pathol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 5
In order to determine the link between cell cycle control and proliferative potential of epidermal progenitor cells by the carboxy-terminus of p63, Invitrogen KRT6A antibody (ThermoFisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5). Development (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to assess the prognostic value of immunohistochemical markers in nonhuman primates, Invitrogen KRT6A antibody (Neo Markers, MS343) was used in immunohistochemistry - paraffin section on human samples at 1:100. Comp Med (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, Invitrogen KRT6A antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Nat Cell Biol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen KRT6A antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Hum Pathol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen KRT6A antibody (Thermo Fisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
In order to determine the role of myofibroblasts in salivary gland adenoid cystic carcinoma invasiveness, Invitrogen KRT6A antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on human samples . Histopathology (2015) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human
In order to compare meningiomas and mesotheliomas immunohistochemically, Invitrogen KRT6A antibody (Thermo Scientific, D5/16 B4) was used in immunohistochemistry - paraffin section on human samples . Biomed Res Int (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human
In order to test if computed tomography-lymphography distinguishes sentinel nodes from non-sentinel nodes in patients with breast cancer, Invitrogen KRT6A antibody (Thermo, AE1/AE3) was used in immunohistochemistry on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
Invitrogen KRT6A antibody (Thermo Fisher, AE1/AE3) was used in immunocytochemistry on human samples . Biomed Mater (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human
In order to determine the predictive criteria of the size of nodal metastases with superparamagnetic iron oxide-enhanced MR imaging in breast cancer, Invitrogen KRT6A antibody (Thermoelectron, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; 1:100
In order to determine the prevalence of BRCA1 germline mutations in young onset TNBC, Invitrogen KRT6A antibody (Zymed Laboratories, Clone D5/16B4) was used in immunohistochemistry on human samples at 1:100. Clin Transl Oncol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to report the clinicopathological features of 9 breast malignant fibrous histiocytoma patients, Invitrogen KRT6A antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Sci Rep (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:100; fig 1
Invitrogen KRT6A antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples at 1:100 (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:200; fig 2
In order to study triple negative breast cancer in Chinese women, Invitrogen KRT6A antibody (Zymed, clone D5/16B4) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2). Int J Clin Exp Pathol (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 1
In order to characterize a case of malignant ossifying fibromyxoid tumor in the tongue, Invitrogen KRT6A antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (tbl 1). Head Face Med (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:200; fig 4
In order to present the third case of thymoma and the second invasive thymoma to metastasize to the cavernous sinus and adjacent to the pituitary, Invitrogen KRT6A antibody (Zymed, AE1-AE3) was used in immunohistochemistry on human samples at 1:200 (fig 4). Surg Neurol Int (2013) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; tbl 3
In order to discuss alterations in claudin 1 localization in basal-like breast cancer subtype, Invitrogen KRT6A antibody (Life Technologies, D5/16B4) was used in immunohistochemistry on human samples (tbl 3). BMC Cancer (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; fig 2
In order to present a case of not otherwise specified-type sarcoma with CD10 expression in the left breast, Invitrogen KRT6A antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (fig 2). Diagn Pathol (2013) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; fig 2
In order to present a case of not otherwise specified-type sarcoma with CD10 expression in the left breast, Invitrogen KRT6A antibody (Invitrogen, D5/16B4) was used in immunohistochemistry on human samples (fig 2). Diagn Pathol (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; Atlantic salmon; 1:50; fig 2
In order to study cell tropism of infectious salmon anemia virus, Invitrogen KRT6A antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on Atlantic salmon samples at 1:50 (fig 2). Virol J (2013) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; dogs; 1:100
In order to determine the relationship between the molecular phenotype of the primary canine mammary tumors and lymph node metastasis, Invitrogen KRT6A antibody (Zymed, D5/16B4) was used in immunohistochemistry - paraffin section on dogs samples at 1:100. BMC Vet Res (2012) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; dogs; 1:100; tbl 2
In order to assess a panel of markers for the identification of four different myoepithelial cell morphological types in normal and neoplastic mammary glands, Invitrogen KRT6A antibody (Zymed, D5/16B4) was used in immunohistochemistry - paraffin section on dogs samples at 1:100 (tbl 2). ScientificWorldJournal (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to review features of choroid plexus carcinoma, Invitrogen KRT6A antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Med Sci Monit (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse
In order to investigate the positioning of taste buds in circumvallate papilla and branching morphogenesis of von Ebners' gland in tongue development, Invitrogen KRT6A antibody (Thermo Scientific, MS-343) was used in immunohistochemistry - paraffin section on mouse samples . Anat Cell Biol (2011) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry - paraffin section; human; 1:100
  • immunocytochemistry; human; 1:100
In order to investigate epithelial to mesenchymal transition during metastasis of pancreatic cancer, Invitrogen KRT6A antibody (Labvision, MS-149) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in immunocytochemistry on human samples at 1:100. Br J Cancer (2012) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human
In order to investigate the clinical and pathological features in a girl with common variable immunodeficiency, Invitrogen KRT6A antibody (Invitrogen, D5/16B4) was used in immunohistochemistry - paraffin section on human samples . Int J Surg Pathol (2014) ncbi
mouse monoclonal (D5/16 B4)
  • immunocytochemistry; human; tbl 1
In order to establish and characterize an epithelial cell line derived from a breast carcinoma from a patient with a strong family history of breast cancer but no known breast cancer susceptibility mutation, Invitrogen KRT6A antibody (Zymed, D5/16B4) was used in immunocytochemistry on human samples (tbl 1). In Vitro Cell Dev Biol Anim (2011) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:50; fig 2, 3, 4
In order to report a new clinical case of prostatic adenomas with abnormal p63 expression, Invitrogen KRT6A antibody (Invitrogen, D5/16B4) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2, 3, 4). Int J Surg Pathol (2011) ncbi
mouse monoclonal (D5/I6 B4)
  • immunohistochemistry; human; 1:50
In order to determine the activation profile of EGFR, PDGFRB, and PDGFRA receptors and their downstream effectors in diffuse malignant peritoneal mesothelioma specimens, Invitrogen KRT6A antibody (Zymed, D5) was used in immunohistochemistry on human samples at 1:50. Eur J Cancer (2010) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry; human; 1:50
In order to determine the activation profile of EGFR, PDGFRB, and PDGFRA receptors and their downstream effectors in diffuse malignant peritoneal mesothelioma specimens, Invitrogen KRT6A antibody (Zymed, D5) was used in immunohistochemistry on human samples at 1:50. Eur J Cancer (2010) ncbi
mouse monoclonal (AE3)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen KRT6A antibody (Zymed, AE3) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (C11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen KRT6A antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen KRT6A antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200
In order to discuss the morphological diversity of glioblastomas, Invitrogen KRT6A antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:200. Cancer (2008) ncbi
mouse monoclonal (D5/16 B4)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 1
In order to determine the effects of chemical oxidation, photo-oxidation, and artificial drying on the degradation of immunoreactivity of tissue samples, Invitrogen KRT6A antibody (Zymed, D5/16B4) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 1). J Clin Pathol (2008) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; fig 5
In order to investigate the effect of COX-2 overexpression on inhibiting proliferation, apoptosis and differentiation, Invitrogen KRT6A antibody (Lab Vision, MS-343-P) was used in western blot on human samples (fig 5). Int J Cancer (2005) ncbi
mouse monoclonal (C11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen KRT6A antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen KRT6A antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:80; tbl 1
In order to describe four cases of oncocytic adrenocortical carcinomas, Invitrogen KRT6A antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:80 (tbl 1). Pathol Int (2004) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; 1:1000; fig 2
In order to study how cell-matrix interactions influence the invasive behavior of a novel, primary peritoneal carcinosarcoma cell line, Invitrogen KRT6A antibody (Zymed, AE1/AE3) was used in western blot on human samples at 1:1000 (fig 2). Gynecol Oncol (2003) ncbi
Abcam
mouse monoclonal (Ks6.KA12)
  • immunohistochemistry; mouse; loading ...; fig 2f
Abcam KRT6A antibody (Abcam, Ab18586) was used in immunohistochemistry on mouse samples (fig 2f). iScience (2022) ncbi
mouse monoclonal (Ks6.KA12)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig e3i
Abcam KRT6A antibody (Abcam, Ks6.KA12) was used in immunohistochemistry - paraffin section on mouse samples (fig e3i). Nature (2019) ncbi
mouse monoclonal (Ks6.KA12)
  • immunohistochemistry - paraffin section; mouse; 1:10; loading ...; fig 3b
Abcam KRT6A antibody (Abcam, ab18586) was used in immunohistochemistry - paraffin section on mouse samples at 1:10 (fig 3b). Clin Sci (Lond) (2017) ncbi
mouse monoclonal (Ks6.KA12)
  • immunohistochemistry; pigs ; 1:200
Abcam KRT6A antibody (Abcam, ab18586) was used in immunohistochemistry on pigs samples at 1:200. J Mater Sci Mater Med (2013) ncbi
Santa Cruz Biotechnology
mouse monoclonal (SPM269)
  • immunohistochemistry; mouse; fig 4a
  • western blot; mouse; 1:1000; loading ...; fig 5a
Santa Cruz Biotechnology KRT6A antibody (Santa Cruz Biotechnology, Sc-56373) was used in immunohistochemistry on mouse samples (fig 4a) and in western blot on mouse samples at 1:1000 (fig 5a). Cells (2022) ncbi
mouse monoclonal (LHK 6)
  • immunocytochemistry; human; fig 2b
In order to examine the effects of the FAM83H mutation on the keratin cytoskeleton and desmosomes in ameloblasts, Santa Cruz Biotechnology KRT6A antibody (Santa Cruz, LHK6) was used in immunocytochemistry on human samples (fig 2b). Sci Rep (2016) ncbi
mouse monoclonal (LHK 6)
  • western blot; human; 1:1000; fig 4
Santa Cruz Biotechnology KRT6A antibody (Santa Cruz, sc-53260) was used in western blot on human samples at 1:1000 (fig 4). BMC Res Notes (2016) ncbi
BioLegend
rat monoclonal (W17006B)
  • immunohistochemistry - paraffin section; human; 1:200; fig s1a
BioLegend KRT6A antibody (Biolegend, 606101) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig s1a). Int J Mol Sci (2022) ncbi
BD Biosciences
mouse monoclonal (CAM 5.2)
  • immunocytochemistry; human; 10 ug/ml; loading ...; fig 2b
BD Biosciences KRT6A antibody (BD, CAM5.2) was used in immunocytochemistry on human samples at 10 ug/ml (fig 2b). BMC Cancer (2020) ncbi
monoclonal (CAM5.2)
  • immunocytochemistry; human; 10 ug/ml; loading ...; fig 2b
BD Biosciences KRT6A antibody (BD, CAM5.2) was used in immunocytochemistry on human samples at 10 ug/ml (fig 2b). BMC Cancer (2020) ncbi
monoclonal (CAM5.2)
  • immunocytochemistry; human; fig 4, 5
BD Biosciences KRT6A antibody (BD Biosciences, CAM5.2) was used in immunocytochemistry on human samples (fig 4, 5). Breast Cancer Res (2019) ncbi
mouse monoclonal (CAM 5.2)
  • immunocytochemistry; human; fig 4, 5
BD Biosciences KRT6A antibody (BD Biosciences, CAM5.2) was used in immunocytochemistry on human samples (fig 4, 5). Breast Cancer Res (2019) ncbi
monoclonal (CAM5.2)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4c
BD Biosciences KRT6A antibody (BD Biosciences, 345779) was used in immunohistochemistry - paraffin section on human samples (fig 4c). J Histochem Cytochem (2018) ncbi
mouse monoclonal (CAM 5.2)
  • flow cytometry; human; 15 ug/ml; loading ...
In order to study the involvement of RANKL in decidual M2 macrophage polarization, BD Biosciences KRT6A antibody (BD Biosciences, 347653) was used in flow cytometry on human samples at 15 ug/ml. Cell Death Dis (2017) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry - paraffin section; human; fig s9b
BD Biosciences KRT6A antibody (BD Bioscience, Cam5.2) was used in immunohistochemistry - paraffin section on human samples (fig s9b). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry - paraffin section; dogs
  • immunohistochemistry; dogs; fig 84
In order to outline the protocols for antibodies used for immunohistochemical studies, BD Biosciences KRT6A antibody (BD Biosciences, 349205) was used in immunohistochemistry - paraffin section on dogs samples and in immunohistochemistry on dogs samples (fig 84). J Toxicol Pathol (2017) ncbi
mouse monoclonal (CAM 5.2)
  • flow cytometry; crab eating macaque; fig 4a
In order to ask if small particle aerosols of virus would penetrate the lower respiratory tract and blanket alveoli where target cells reside, BD Biosciences KRT6A antibody (BD Biosciences, CAM5.2) was used in flow cytometry on crab eating macaque samples (fig 4a). J Immunol (2017) ncbi
mouse monoclonal (CAM 5.2)
  • immunocytochemistry; human; loading ...; fig 5a
In order to suggest that EGFR promotes survival of prostate tumor-initiating cells and circulating tumor cells that metastasize to bone, whereas HER2 supports the growth of prostate cancer cells once they are established at metastatic sites, BD Biosciences KRT6A antibody (BD Biosciences, CAM5.2) was used in immunocytochemistry on human samples (fig 5a). Cancer Res (2017) ncbi
mouse monoclonal (CAM 5.2)
  • immunocytochemistry; human; 1:600; loading ...; fig 4
In order to develop methods to capture circulating tumor cells using transparent nanomaterials and quantum dots-based multiplexed imaging, BD Biosciences KRT6A antibody (BD Biosciences, BD-349205) was used in immunocytochemistry on human samples at 1:600 (fig 4). J Cancer (2016) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry; human
BD Biosciences KRT6A antibody (BD Biosciences, CAM 5.2) was used in immunohistochemistry on human samples . Virchows Arch (2015) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry; human
BD Biosciences KRT6A antibody (Becton Dickinson, CAM5.2) was used in immunohistochemistry on human samples . Int J Clin Exp Pathol (2015) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry - paraffin section; human; fig 3
BD Biosciences KRT6A antibody (BD Biosciences, Cam5.2) was used in immunohistochemistry - paraffin section on human samples (fig 3). Nature (2015) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry - paraffin section; human
In order to study the role of neural stem cells in the pathogenesis of CNS lymphomas, BD Biosciences KRT6A antibody (Becton Dickinson, 349205) was used in immunohistochemistry - paraffin section on human samples . Springerplus (2015) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry - paraffin section; human; 1:10
In order to describe a case of marginal zone lymphoma with extensive emperipolesis, BD Biosciences KRT6A antibody (BD Biosciences, CAM5.2) was used in immunohistochemistry - paraffin section on human samples at 1:10. Cytopathology (2016) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry - paraffin section; human; 1:1
BD Biosciences KRT6A antibody (Becton Dickinson Immunocytometry Systems, Cam5.2) was used in immunohistochemistry - paraffin section on human samples at 1:1. World J Gastroenterol (2015) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry - paraffin section; human; 1:20
BD Biosciences KRT6A antibody (BD, Cam 5.2) was used in immunohistochemistry - paraffin section on human samples at 1:20. Endocr Pathol (2014) ncbi
mouse monoclonal (CAM 5.2)
  • immunocytochemistry; human
BD Biosciences KRT6A antibody (Beckton Dickinson, CAM5.2) was used in immunocytochemistry on human samples . J Cancer (2014) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry - paraffin section; human
BD Biosciences KRT6A antibody (Becton-Dickinson, CAM5.2) was used in immunohistochemistry - paraffin section on human samples . Oncol Lett (2014) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry; dogs
BD Biosciences KRT6A antibody (Becton Dickinson, CAM5.2) was used in immunohistochemistry on dogs samples . J Comp Pathol (2014) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry; human
In order to study salivary duct carcinoma with rhabdoid features, BD Biosciences KRT6A antibody (Becton Dickinson, CAM5.2) was used in immunohistochemistry on human samples . Head Neck (2014) ncbi
mouse monoclonal (CAM 5.2)
  • immunohistochemistry; human
In order to investigate the thymus development, BD Biosciences KRT6A antibody (Becton, CAM 5.2) was used in immunohistochemistry on human samples . Development (2013) ncbi
Articles Reviewed
  1. Canesin G, Feldbr xfc gge L, Wei G, Janovičová Ľ, Janikova M, Csizmadia E, et al. Heme oxygenase-1 mitigates liver injury and fibrosis via modulation of LNX1/Notch1 pathway in myeloid cells. iScience. 2022;25:104983 pubmed publisher
  2. Bhattacharya N, INDRA A, Ganguli Indra G. Selective Ablation of BCL11A in Epidermal Keratinocytes Alters Skin Homeostasis and Accelerates Excisional Wound Healing In Vivo. Cells. 2022;11: pubmed publisher
  3. Koliakou E, Eleni M, Koumentakou I, Bikiaris N, Konstantinidou P, Rousselle P, et al. Altered Distribution and Expression of Syndecan-1 and -4 as an Additional Hallmark in Psoriasis. Int J Mol Sci. 2022;23: pubmed publisher
  4. Rodriguez E, Boelaars K, Brown K, Madunić K, van Ee T, Dijk F, et al. Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits. Commun Biol. 2022;5:41 pubmed publisher
  5. Bruun J, Eide P, Bergsland C, Brück O, Svindland A, Arjama M, et al. E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models. Mol Oncol. 2022;16:2312-2329 pubmed publisher
  6. Barthet V, Brucoli M, Ladds M, Nössing C, Kiourtis C, Baudot A, et al. Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver. Sci Adv. 2021;7: pubmed publisher
  7. Levi M, Muscatello L, Brunetti B, Benazzi C, Parenti F, Gobbo F, et al. High Intrinsic Expression of P-glycoprotein and Breast Cancer Resistance Protein in Canine Mammary Carcinomas Regardless of Immunophenotype and Outcome. Animals (Basel). 2021;11: pubmed publisher
  8. Rodriguez E, Boelaars K, Brown K, Eveline Li R, Kruijssen L, Bruijns S, et al. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Nat Commun. 2021;12:1270 pubmed publisher
  9. Biasci D, Smoragiewicz M, Connell C, Wang Z, Gao Y, Thaventhiran J, et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc Natl Acad Sci U S A. 2020;117:28960-28970 pubmed publisher
  10. Ortiz Otero N, Marshall J, Lash B, King M. Chemotherapy-induced release of circulating-tumor cells into the bloodstream in collective migration units with cancer-associated fibroblasts in metastatic cancer patients. BMC Cancer. 2020;20:873 pubmed publisher
  11. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed publisher
  12. Gaglia G, Rashid R, Yapp C, Joshi G, Li C, Lindquist S, et al. HSF1 phase transition mediates stress adaptation and cell fate decisions. Nat Cell Biol. 2020;22:151-158 pubmed publisher
  13. Strickley J, Messerschmidt J, Awad M, Li T, Hasegawa T, Ha D, et al. Immunity to commensal papillomaviruses protects against skin cancer. Nature. 2019;: pubmed publisher
  14. Ramani V, Lemaire C, Triboulet M, Casey K, Heirich K, Renier C, et al. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Breast Cancer Res. 2019;21:98 pubmed publisher
  15. Kim J, Villadsen R. Expression of Luminal Progenitor Marker CD117 in the Human Breast Gland. J Histochem Cytochem. 2018;66:879-888 pubmed publisher
  16. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  17. Aprile F, Källstig E, Limorenko G, Vendruscolo M, Ron D, Hansen C. The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation. Sci Rep. 2017;7:9039 pubmed publisher
  18. Wang X, Xia Q, Ni H, Ye S, Li R, Wang X, et al. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Hum Pathol. 2017;63:190-200 pubmed publisher
  19. Fumagalli A, Drost J, Suijkerbuijk S, van Boxtel R, de Ligt J, Offerhaus G, et al. Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids. Proc Natl Acad Sci U S A. 2017;114:E2357-E2364 pubmed publisher
  20. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  21. Kwon Y, Stanciu C, Philpott M, Ehrhardt C. Flow cytometry dataset for cells collected from touched surfaces. F1000Res. 2016;5:390 pubmed publisher
  22. Irrera N, Vaccaro M, Bitto A, Pallio G, Pizzino G, Lentini M, et al. BAY 11-7082 inhibits the NF-?B and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis. Clin Sci (Lond). 2017;131:487-498 pubmed publisher
  23. Wonderlich E, Swan Z, Bissel S, Hartman A, Carney J, O Malley K, et al. Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques. J Immunol. 2017;198:1616-1626 pubmed publisher
  24. Foster M, Gwinn W, Kelly F, Brass D, Valente A, Moseley M, et al. Proteomic Analysis of Primary Human Airway Epithelial Cells Exposed to the Respiratory Toxicant Diacetyl. J Proteome Res. 2017;16:538-549 pubmed publisher
  25. De Luca Johnson J, Zenali M. A Previously Undescribed Presentation of Mixed Adenoneuroendocrine Carcinoma. Case Rep Pathol. 2016;2016:9063634 pubmed
  26. Day K, Lorenzatti Hiles G, Kozminsky M, Dawsey S, Paul A, Broses L, et al. HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to Bone. Cancer Res. 2017;77:74-85 pubmed publisher
  27. Hsieh M, Wang H, Lee Y, Ko J, Chang Y. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation. Hum Pathol. 2017;61:9-18 pubmed publisher
  28. Berens E, Sharif G, Schmidt M, Yan G, Shuptrine C, Weiner L, et al. Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion. Oncogene. 2017;36:593-605 pubmed publisher
  29. Szalayova G, Ogrodnik A, Spencer B, Wade J, Bunn J, Ambaye A, et al. Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation. Breast Cancer Res Treat. 2016;157:461-74 pubmed publisher
  30. Kuga T, Sasaki M, Mikami T, Miake Y, Adachi J, Shimizu M, et al. FAM83H and casein kinase I regulate the organization of the keratin cytoskeleton and formation of desmosomes. Sci Rep. 2016;6:26557 pubmed publisher
  31. Kokado M, Okada Y, Miyamoto T, Yamanaka O, Saika S. Effects of epiplakin-knockdown in cultured corneal epithelial cells. BMC Res Notes. 2016;9:278 pubmed publisher
  32. Fabbri R, Macciocca M, Vicenti R, Paradisi R, Klinger F, Pasquinelli G, et al. Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue. Future Oncol. 2016;12:1699-711 pubmed publisher
  33. Chen Y, Cheng B, He Z, Wang S, Wang Z, Sun M, et al. Capture and Identification of Heterogeneous Circulating Tumor Cells Using Transparent Nanomaterials and Quantum Dots-Based Multiplexed Imaging. J Cancer. 2016;7:69-79 pubmed publisher
  34. Shin H, Pei Z, Martinez K, Rivera Viñas J, Méndez K, Cavallin H, et al. The first microbial environment of infants born by C-section: the operating room microbes. Microbiome. 2015;3:59 pubmed publisher
  35. Gao L, Jiang Y, Mu L, Liu Y, Wang F, Wang P, et al. Efficient Generation of Mice with Consistent Transgene Expression by FEEST. Sci Rep. 2015;5:16284 pubmed publisher
  36. Jung M, Ryu Y, Kang G. Investigation of the origin of stromal and endothelial cells at the desmoplastic interface in xenograft tumor in mice. Pathol Res Pract. 2015;211:925-30 pubmed publisher
  37. Li Y, Adomat H, Guns E, Hojabrpour P, Duronio V, Curran T, et al. Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor. J Cell Physiol. 2016;231:1350-63 pubmed publisher
  38. KapucuoÄŸlu N, Bozkurt K, BaÅŸpınar Å, Koçer M, EroÄŸlu H, Akdeniz R, et al. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer. Pathol Res Pract. 2015;211:740-7 pubmed publisher
  39. Sauter J, Ambaye A, Mount S. Increased utilization, verification, and clinical implications of immunocytochemistry: Experience in a northern New England hospital. Diagn Cytopathol. 2015;43:688-95 pubmed publisher
  40. Swaminathan T, Basheer V, Kumar R, Kathirvelpandian A, Sood N, Jena J. Establishment and characterization of fin-derived cell line from ornamental carp, Cyprinus carpio koi, for virus isolation in India. In Vitro Cell Dev Biol Anim. 2015;51:705-13 pubmed publisher
  41. Vanoli A, Argenti F, Vinci A, La Rosa S, Viglio A, Riboni R, et al. Hepatoid carcinoma of the pancreas with lymphoid stroma: first description of the clinical, morphological, immunohistochemical, and molecular characteristics of an unusual pancreatic carcinoma. Virchows Arch. 2015;467:237-45 pubmed publisher
  42. Muhanna N, Mepham A, Mohamadi R, Chan H, Khan T, Akens M, et al. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model. Nanomedicine. 2015;11:1613-20 pubmed publisher
  43. Kuroda N, Agatsuma Y, Tamura M, Martinek P, Hes O, Michal M. Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma. Int J Clin Exp Pathol. 2015;8:2131-8 pubmed
  44. Kershaw S, Cummings J, Morris K, Tugwood J, Dive C. Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells. BMC Cancer. 2015;15:387 pubmed publisher
  45. Katanov C, Lerrer S, Liubomirski Y, Leider Trejo L, Meshel T, Bar J, et al. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-? and the NF-?B pathway. Stem Cell Res Ther. 2015;6:87 pubmed publisher
  46. Drost J, van Jaarsveld R, Ponsioen B, Zimberlin C, van Boxtel R, Buijs A, et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature. 2015;521:43-7 pubmed publisher
  47. Sood N, Chaudhary D, Pradhan P, Verma D, Raja Swaminathan T, Kushwaha B, et al. Establishment and characterization of a continuous cell line from thymus of striped snakehead, Channa striatus (Bloch 1793). In Vitro Cell Dev Biol Anim. 2015;51:787-96 pubmed publisher
  48. Campbell J, Miller D, Cundiff D, Feng Q, Litofsky N. Neural stem/progenitor cells react to non-glial cns neoplasms. Springerplus. 2015;4:53 pubmed publisher
  49. Ahmed H, Abdul Gader Suliman R, Abd El Aziz M, Alshammari F. Immunohistochemical expression of cytokeratins and epithelial membrane protein 2 in nasopharyngeal carcinoma and its potential implications. Asian Pac J Cancer Prev. 2015;16:653-6 pubmed
  50. Meykler S, Baloch Z, Barroeta J. A case of marginal zone lymphoma with extensive emperipolesis diagnosed on pleural effusion cytology with immunocytochemistry and flow cytometry. Cytopathology. 2016;27:70-2 pubmed publisher
  51. Muscatello L, Sarli G, Beha G, Asproni P, Millanta F, Poli A, et al. Validation of tissue microarray for molecular profiling of canine and feline mammary tumours. J Comp Pathol. 2015;152:153-60 pubmed publisher
  52. Yamada S, Nabeshima A, Noguchi H, Nawata A, Nishii H, Guo X, et al. Coincidence between malignant perivascular epithelioid cell tumor arising in the gastric serosa and lung adenocarcinoma. World J Gastroenterol. 2015;21:1349-56 pubmed publisher
  53. Zheng L, Cardaci S, Jerby L, MacKenzie E, Sciacovelli M, Johnson T, et al. Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat Commun. 2015;6:6001 pubmed publisher
  54. Moser B, Schiefer A, Janik S, Marx A, Prosch H, Pohl W, et al. Adenocarcinoma of the thymus, enteric type: report of 2 cases, and proposal for a novel subtype of thymic carcinoma. Am J Surg Pathol. 2015;39:541-8 pubmed publisher
  55. Suzuki D, Sahu R, Leu N, Senoo M. The carboxy-terminus of p63 links cell cycle control and the proliferative potential of epidermal progenitor cells. Development. 2015;142:282-90 pubmed publisher
  56. Beck A, Brooks A, Zeiss C. Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta). Comp Med. 2014;64:314-22 pubmed
  57. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
  58. Kasem K, Lam A. Adrenal oncocytic phaeochromocytoma with putative adverse histologic features: a unique case report and review of the literature. Endocr Pathol. 2014;25:416-21 pubmed publisher
  59. Li L, Fan X, Xia Q, Rao Q, Liu B, Yu B, et al. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis. Hum Pathol. 2014;45:2247-54 pubmed publisher
  60. Costache M, Pătraşcu O, Dumitru A, Costache D, Voinea L, Simionescu O, et al. Histopathological findings concerning ocular melanomas. Rom J Morphol Embryol. 2014;55:649-53 pubmed
  61. Guan H, Tan J, Zhang F, Gao L, Bai L, Qi D, et al. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12. Histopathology. 2015;66:781-90 pubmed publisher
  62. Abdelzaher E, Abdallah D. Expression of mesothelioma-related markers in meningiomas: an immunohistochemical study. Biomed Res Int. 2014;2014:968794 pubmed publisher
  63. Woodward W, Krishnamurthy S, Lodhi A, Xiao L, Gong Y, Cristofanilli M, et al. Aldehyde dehydrogenase1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cells. J Cancer. 2014;5:360-7 pubmed publisher
  64. Ishida M, Iwai M, Yoshida K, Kagotani A, Okabe H. Signet-ring cell melanoma with sentinel lymph node metastasis: A case report with immunohistochemical analysis and review of the clinicopathological features. Oncol Lett. 2014;7:65-68 pubmed
  65. Motomura K, Sumino H, Noguchi A, Horinouchi T, Nakanishi K. Sentinel nodes identified by computed tomography-lymphography accurately stage the axilla in patients with breast cancer. BMC Med Imaging. 2013;13:42 pubmed publisher
  66. Yasuno K, Nishiyama S, Kobayashi R, Yoshimura H, Takahashi K, Omachi T, et al. Proliferative lesions of intra-epidermal cytokeratin CAM5.2-positive cells in canine nipples. J Comp Pathol. 2014;150:18-26 pubmed publisher
  67. Bulysheva A, Bowlin G, Petrova S, Yeudall W. Enhanced chemoresistance of squamous carcinoma cells grown in 3D cryogenic electrospun scaffolds. Biomed Mater. 2013;8:055009 pubmed publisher
  68. Kusafuka K, Onitsuka T, Muramatsu K, Miki T, Murai C, Suda T, et al. Salivary duct carcinoma with rhabdoid features: report of 2 cases with immunohistochemical and ultrastructural analyses. Head Neck. 2014;36:E28-35 pubmed publisher
  69. Motomura K, Izumi T, Tateishi S, Sumino H, Noguchi A, Horinouchi T, et al. Correlation between the area of high-signal intensity on SPIO-enhanced MR imaging and the pathologic size of sentinel node metastases in breast cancer patients with positive sentinel nodes. BMC Med Imaging. 2013;13:32 pubmed publisher
  70. Andres R, Pajares I, Balmana J, Llort G, Ramon Y Cajal T, Chirivella I, et al. Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC). Clin Transl Oncol. 2014;16:280-4 pubmed publisher
  71. Qiu S, Wei X, Huang W, Wu M, Qin Y, Li Y, et al. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013;3:2529 pubmed publisher
  72. Hosokawa M, Kenmotsu H, Koh Y, Yoshino T, Yoshikawa T, Naito T, et al. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system. PLoS ONE. 2013;8:e67466 pubmed publisher
  73. Holt B, Betz D, Ford T, Beck J, BLOEBAUM R, Jeyapalina S. Pig dorsum model for examining impaired wound healing at the skin-implant interface of percutaneous devices. J Mater Sci Mater Med. 2013;24:2181-93 pubmed publisher
  74. Zhang J, Wang Y, Yin Q, Zhang W, Zhang T, Niu Y. An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy. Int J Clin Exp Pathol. 2013;6:1380-91 pubmed
  75. Ohta K, Taki M, Ogawa I, Ono S, Mizuta K, Fujimoto S, et al. Malignant ossifying fibromyxoid tumor of the tongue: case report and review of the literature. Head Face Med. 2013;9:16 pubmed publisher
  76. Nassiri F, Scheithauer B, Corwin D, Kaplan H, Mayberg M, Cusimano M, et al. Invasive thymoma metastatic to the cavernous sinus. Surg Neurol Int. 2013;4:74 pubmed publisher
  77. Blanchard A, Ma X, Dueck K, Penner C, Cooper S, Mulhall D, et al. Claudin 1 expression in basal-like breast cancer is related to patient age. BMC Cancer. 2013;13:268 pubmed publisher
  78. Farley A, Morris L, Vroegindeweij E, Depreter M, Vaidya H, Stenhouse F, et al. Dynamics of thymus organogenesis and colonization in early human development. Development. 2013;140:2015-26 pubmed publisher
  79. Yang G, Li J, Jin H, Ding H. Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study. Diagn Pathol. 2013;8:14 pubmed publisher
  80. Weli S, Aamelfot M, Dale O, Koppang E, Falk K. Infectious salmon anaemia virus infection of Atlantic salmon gill epithelial cells. Virol J. 2013;10:5 pubmed publisher
  81. Beha G, Brunetti B, Asproni P, Muscatello L, Millanta F, Poli A, et al. Molecular portrait-based correlation between primary canine mammary tumor and its lymph node metastasis: possible prognostic-predictive models and/or stronghold for specific treatments?. BMC Vet Res. 2012;8:219 pubmed publisher
  82. Beha G, Sarli G, Brunetti B, Sassi F, Ferrara D, Benazzi C. Morphology of the myoepithelial cell: immunohistochemical characterization from resting to motile phase. ScientificWorldJournal. 2012;2012:252034 pubmed publisher
  83. Lv S, Song Y, Xu J, Shu H, Zhou Z, An N, et al. A novel TP53 somatic mutation involved in the pathogenesis of pediatric choroid plexus carcinoma. Med Sci Monit. 2012;18:CS37-41 pubmed
  84. Sohn W, Gwon G, An C, Moon C, Bae Y, Yamamoto H, et al. Morphological evidences in circumvallate papilla and von Ebners' gland development in mice. Anat Cell Biol. 2011;44:274-83 pubmed publisher
  85. Khoja L, Backen A, Sloane R, Menasce L, Ryder D, Krebs M, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106:508-16 pubmed publisher
  86. Petrilli G, Lorenzi L, Paracchini R, Ubiali A, Schumacher R, Cabassa P, et al. Epstein-Barr virus-associated adrenal smooth muscle tumors and disseminated diffuse large B-cell lymphoma in a child with common variable immunodeficiency: a case report and review of the literature. Int J Surg Pathol. 2014;22:712-21 pubmed publisher
  87. Ingthorsson S, Halldorsson T, Sigurdsson V, Friðriksdottir A, Bodvarsdottir S, Steinarsdottir M, et al. Selection for EGFR gene amplification in a breast epithelial cell line with basal-like phenotype and hereditary background. In Vitro Cell Dev Biol Anim. 2011;47:139-48 pubmed publisher
  88. Baydar D, Kulac I, Gurel B, De Marzo A. A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis. Int J Surg Pathol. 2011;19:131-6 pubmed publisher
  89. Perrone F, Jocollè G, Pennati M, Deraco M, Baratti D, Brich S, et al. Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma. Eur J Cancer. 2010;46:2837-48 pubmed publisher
  90. Gil da Costa R, Santos M, Amorim I, Lopes C, Pereira P, Faustino A. An immunohistochemical study of feline endometrial adenocarcinoma. J Comp Pathol. 2009;140:254-9 pubmed publisher
  91. Rhee K, Wu S, Wu X, Huso D, Karim B, Franco A, et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun. 2009;77:1708-18 pubmed publisher
  92. Rodriguez F, Scheithauer B, Giannini C, Bryant S, Jenkins R. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer. 2008;113:2779-89 pubmed publisher
  93. Blind C, Koepenik A, Pacyna Gengelbach M, Fernahl G, Deutschmann N, Dietel M, et al. Antigenicity testing by immunohistochemistry after tissue oxidation. J Clin Pathol. 2008;61:79-83 pubmed
  94. Lu S, Yu G, Zhu Y, Archer M. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int J Cancer. 2005;116:847-52 pubmed
  95. Gilbert S, Loranger A, Marceau N. Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells. Mol Cell Biol. 2004;24:7072-81 pubmed
  96. Song S, Park S, Kim S, Suh Y. Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas. Pathol Int. 2004;54:603-10 pubmed
  97. Kokenyesi R, Murray K, Benshushan A, Huntley E, Kao M. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression. Gynecol Oncol. 2003;89:60-72 pubmed